We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$65.3M
Cap. Flow
+$26.2M
Cap. Flow %
5.96%
Top 10 Hldgs %
48.81%
Holding
93
New
22
Increased
21
Reduced
16
Closed
33

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$33.8M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$24.3M
3
AGN
Allergan plc
AGN
+$16M
4
CCI icon
Crown Castle
CCI
+$10.7M
5
ANDV
Andeavor
ANDV
+$10.7M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$16.1M
2
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
+$11M
3
DG icon
Dollar General
DG
+$10.8M
4
PARA
Paramount Global Class B
PARA
+$10.3M
5
CMI icon
Cummins
CMI
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.64%
2 Communication Services 13.84%
3 Real Estate 10.92%
4 Energy 8.35%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRA
26
DELISTED
Coterra Energy
CTRA
$6.92M 1.57%
+178,548
New +$6.37M
BIDU icon
27
Baidu
BIDU
$37.1B
$6.22M 1.41%
34,981
-38,689
-53% -$6.25M
MPC icon
28
Marathon Petroleum
MPC
$84B
$5.62M 1.27%
+122,438
New +$4.71M
TMO icon
29
Thermo Fisher Scientific
TMO
$214B
$5.53M 1.25%
49,667
-161,729
-77% -$16.1M
MHFI
30
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$5.32M 1.21%
+68,082
New +$4.89M
PARA
31
DELISTED
Paramount Global Class B
PARA
$4.24M 0.96%
66,569
-175,636
-73% -$10.3M
HNT
32
DELISTED
HEALTH NET INC
HNT
$4.24M 0.96%
142,891
+111,005
+348% +$3.32M
NFLX icon
33
Netflix
NFLX
$307B
$4.08M 0.93%
775,530
-1,680
-0.2% -$8.24K
MDCO
34
DELISTED
Medicines Co
MDCO
$4.01M 0.91%
103,974
-19,361
-16% -$692K
WDAY icon
35
Workday
WDAY
$42B
$3.61M 0.82%
+43,393
New +$3.43M
AGN
36
DELISTED
Allergan Inc
AGN
$3.09M 0.7%
+27,829
New +$2.66M
OREX
37
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.35M 0.31%
24,022
+6,163
+35% +$346K
AUXL
38
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$1.27M 0.29%
61,276
+20,994
+52% +$396K
THC icon
39
Tenet Healthcare
THC
$20.7B
$1.24M 0.28%
29,507
+15,351
+108% +$668K
KYTH
40
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$982K 0.22%
26,295
+2,700
+11% +$112K
RPRX
41
DELISTED
Repros Therapeutics Inc.
RPRX
$890K 0.2%
48,607
+25,510
+110% +$482K
PFE icon
42
Pfizer
PFE
$149B
$806K 0.18%
27,745
-230,629
-89% -$6.71M
COO icon
43
Cooper Companies
COO
$14.3B
$747K 0.17%
24,116
+12,492
+107% +$398K
KPTI icon
44
Karyopharm Therapeutics
KPTI
$44.2M
$662K 0.15%
+2,009
New +$555K
BRKR icon
45
Bruker
BRKR
$7.8B
$617K 0.14%
31,222
-4,217
-12% -$82.7K
MCK icon
46
McKesson
MCK
$102B
$598K 0.14%
3,702
+337
+10% +$51.8K
ANAC
47
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$559K 0.13%
+33,292
New +$461K
DNDN
48
DELISTED
DENDREON CORPORATION
DNDN
$458K 0.1%
+153,234
New +$431K
HUM icon
49
Humana
HUM
$44.1B
$431K 0.1%
4,178
+344
+9% +$33.7K
REGN icon
50
Regeneron Pharmaceuticals
REGN
$79.5B
$424K 0.1%
1,542
-16,673
-92% -$4.8M
1
2
3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Partner Investment Management held 93 positions worth $441M, up 17% from $375M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Partner Investment Management deployed $26.2M of net new capital in Q4 2013, opening 22 new positions and adding to 21 existing holdings. Its largest new stake was Bristol-Myers Squibb: 662,798 shares worth $35.2M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 28% a quarter earlier, followed by Communication Services and Real Estate.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $16.1M trimmed.

  • Partner Investment Management's largest Q4 2013 buy was Bristol-Myers Squibb: 662,798 shares worth $35.2M.
  • Partner Investment Management added most to Allergan plc in Q4 2013, an estimated $16M increase.
  • Partner Investment Management's biggest Q4 2013 reduction was Thermo Fisher Scientific, cutting an estimated $16.1M.
  • Partner Investment Management fully exited CAMERON INTERNATIONAL CORPORATION in Q4 2013, selling an estimated $11M.
  • Partner Investment Management's ten largest holdings make up 49% of its $441M portfolio in Q4 2013.
  • Partner Investment Management opened 22 new positions and closed 33 in Q4 2013.
  • Partner Investment Management's portfolio value rose 17% quarter-over-quarter to $441M.

Based on Partner Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.